Clinical case studies on medication safety /

Clinical Case Studies on Medication Safety provides real and simulated scenarios about safety issues related to medication, including Adverse Drug Reactions (ADRs), medication errors, and Drug Related Problems (DRPs). The book explains real-life case management, including details about adverse drug...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Al-Worafi, Yaser (Editor)
Format: eBook
Language:English
Published: London ; San Diego, CA : Academic Press, an imprint of Elsevier, [2023]
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Intro
  • Clinical Case Studies on Medication Safety
  • Copyright
  • Dedication
  • Contents
  • Contributors
  • Preface
  • Acknowledgments
  • Chapter 1: Introduction to the medication safety and the importance of clinical case studies
  • 1. Background
  • 2. The scope of the present textbook
  • 3. Key features
  • References
  • Chapter 2: Adverse drug reactions (ADRs) case studies: Mild ADRs
  • 1. Background
  • Terminologies
  • Factors affecting the development of adverse drug reactions (ADRs)
  • Prevention of adverse drug reactions (ADRs) prevention and management
  • 2. Cases
  • Case 1. Case of nausea-Metformin
  • Case 2. Case of vomiting-Amoxicillin/clavulanate
  • Case 3. Case of ankle edema-Amlodipine
  • Case 4. Case of headache-Sildenafil
  • Case 5. Case of constipation-Iron
  • Case 6. Case of diarrhea-Amoxicillin
  • Case 7. Case of stomach pain-Ibuprofen
  • Case 8. Case of skin burning and reddened-Salicylic acid
  • Case 9. Case of muscle pain-Statin
  • Case 10. Case of skin dryness-Isotretinoin
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further Reading
  • Chapter 3: Adverse drug reactions (ADRs) case studies: Moderate ADRs
  • 1. Background
  • Classifications of adverse drug reactions
  • Management of adverse drug reactions
  • Cases presentations
  • 2. Case studies
  • Case of drug allergies, antibiotics, penicillin
  • Case of drug-drug/herbal interactions, CYP450 inducers-St Johns Wort, warfarin
  • Case of acute kidney injuries, contrast media
  • Case of hyperkalemia, aldosterone receptor antagonists-Spironolactone
  • Case of hypoglycemia, sulfonylureas-Glimepiride
  • Case of acute bleeding, DOACs-Apixaban
  • Case of withdrawal effects, steroids-Prednisone
  • Case of significant side effects, methotrexate
  • Case of narrow therapeutic index drugs, digoxin
  • Case of QTC prolongation, amiodarone/ciprofloxacin.
  • Case of myopathy due to poor function phenotype reduced hepatic uptake of the active form of Simvastatin
  • Case of DPYD genotype: 5-FU intermediate metabolizer and Diarrhea due to 5-FU accumulation
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Chapter 4: Adverse drug reactions (ADRs) case studies: Severe ADRs
  • 1. Background
  • Terminologies
  • Factors affecting the development of adverse drug reactions (ADRs)
  • Prevention of adverse drug reactions (ADRs) prevention and management
  • 2. Cases
  • Case 1. Case of acute kidney injury-Ceftriaxone
  • Case 2. Case of gastrointestinal bleeding-Aspirin
  • Case 3. Case of gastrointestinal bleeding-Naproxen
  • Case 4. Case of vision impairment-Sildenafil
  • Case 5. Case of hepatotoxicity-Ketoconazole
  • Case 6. Case of hepatotoxicity-Statin
  • Case 7. Case of rhabdomyolysis-Statin
  • Case 8. Case of electrolyte abnormalities and rhabdomyolysis-Furosemide
  • Case 9. Case of hepatotoxicity-Paracetamol
  • Case 10. Case of electrolyte abnormalities-Laxatives
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Chapter 5: Medication errors case studies: Prescribing, transcribing, and prescriptions/orders writing errors
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1. Case of stable angina
  • Case 2. Case of asthma
  • Case 3. Case of diabetes mellitus type 2, hypertension, and dyslipidemia
  • Case 4. Case of epilepsy
  • Case 6. Case of dyslipidemia
  • Case 7. Case of epilepsy
  • Case 8. Case of dyslipidemia
  • 3. Prescription writing errors
  • 4. Conclusion
  • 5. Educational resources
  • References
  • Chapter 6: Medication errors case studies: Dispensing and administration errors
  • 1. Background
  • Terminologies
  • 2. Cases: Dispensing errors
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • 3. Cases: Administration errors
  • Case 1.
  • Case 2
  • Case 3
  • Case 4
  • 4. Conclusion
  • 5. Educational resources
  • References
  • Chapter 7: Medication errors case studies: Monitoring and counseling errors
  • 1. Background
  • Terminologies
  • 2. Cases: Monitoring errors
  • Case 1
  • Case 2
  • Case 3
  • Case 4. Case of diabetes mellitus type 2 and hypertension
  • Case 5
  • Case 6
  • 3. Cases: Education and counseling errors
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • 4. Conclusion
  • 5. Educational resources
  • References
  • Further reading
  • Chapter 8: Medication errors case studies: Medication reconciliation errors
  • 1. Background
  • 2. Case 1
  • 3. Case 2
  • 4. Case 3
  • 5. Case 4
  • 6. Case 5
  • 7. Case 6
  • 8. Case 7
  • 9. Case 8
  • 10. Case 9
  • 11. Case 10
  • 12. Conclusion
  • 13. Educational resources
  • References
  • Chapter 9: Drug interactions case studies
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • Case 9
  • Case 10
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Chapter 10: Adherence, compliance, and persistence case studies
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • Case 9
  • Case 10
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Chapter 11: Drug-related problems case studies: Part I
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Chapter 12: Drug-related problems case studies: Part II
  • 1. Background
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 5
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Chapter 13: Counterfeit and substandard medications case studies
  • 1. Background
  • Terminologies.
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Chapter 14: Medications misuse and abuse case studies
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • Case 9
  • Case 10
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Chapter 15: Medications safety for special population case studies: Geriatrics
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • Case 9
  • Case 10
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Chapter 16: Medications safety for special population case studies: Pediatrics
  • 1. Background
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • Case 9
  • Case 10
  • 3. Conclusion
  • References
  • Chapter 17: Medications safety for special population case studies: Pregnancy
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • Case 9
  • Case 10
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Chapter 18: Medications safety for special population case studies: Lactation
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • Case 9
  • Case 10
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Chapter 19: Herbal medicines case studies: Part I
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Chapter 20: Herbal medicines case studies: Part II
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2.
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Chapter 21: Antibiotics case studies: Community pharmacies and primary care and public
  • 1. Background
  • Terminologies
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Chapter 22: Antibiotics safety case studies: Hospitals
  • 1. Background
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • Case 6
  • Case 7
  • Case 8
  • Case 9
  • Case 10
  • References
  • Chapter 23: Vaccines safety case studies
  • 1. Background
  • Terminologies
  • Prevention of adverse drug reactions (ADRs) prevention and management
  • 2. Cases
  • Case 1
  • Case 2
  • Case 3
  • Case 4
  • Case 5
  • 3. Conclusion
  • 4. Educational resources
  • References
  • Further reading
  • Index.